Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

458 Impact of pretreatment steroid use on neutrophiltolymphocyte ratio in patients with NSCLC receiving immunotherapy-based frontline therapy

  • Christian Rolfo1
  • Lai Wei2
  • Peter Shields3
  • Jian Hu4
  • Songzhu Zhao5
  • Bobak Parang6
  • Mingjia Li7
  • Asrar Alahmadi8
  • Carolyn Presley3
  • Daniel Spakowicz1
  • Jacob Kaufman9
  • Timothy Burns10
12 more authors
  • Kenneth Chian3
  • Logan Roof3
  • Regan Memmott3
  • Nikhil Sekar1
  • Jinesh S Gheeya11
  • Dwight H Owen12
  • Vayda Barker1
  • Shriya Deshmukh11
  • Jennifer Hwang1
  • Sahana Aiyer1
  • Sushma Jonna1
  • David P Carbone11
12 affiliations
  1. 1The Ohio State University Wexner Medical Center, Columbus, OH, USA
  2. 23 Department of Radiotherapy, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  3. 31The Ohio State University, Columbus, OH, USA
  4. 4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  5. 58 Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA
  6. 61Division of Gastroenterology, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA
  7. 7Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA
  8. 810The Ohio State University, Columbus, OH, USA
  9. 95The Ohio State University James Cancer Hospital, Columbus, OH, USA
  10. 107The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
  11. 11The Ohio State University James Comprehensive Cancer Center, Columbus, OH, USA
  12. 12The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
Open at sourcePDFDOICite

Related

  1. 994 Predicting immune-related inflammatory arthritis in patients with cancer receiving immunotherapy
    Namrata Singh, Pankti Reid, Wooyoung Kim +3
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYOncologyDOAJ
  2. Pretreatment Prognostic Nutritional Index Is Associated with Treatment Response and Survival in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Receiving CAR-T Cell Therapy
    Zhengyuan Han, Yadi Zhong, Zijian Lv +2
    NutrientsPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  3. Financial toxicity profiles and associated factors among lung cancer patients receiving immunotherapy: a latent profile analysis
    Jing Nie, Peijuan Hu, Wei Qian +2
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
  4. Impact of different TP53 mutation subtypes on response and outcome in advanced lung adenocarcinoma receiving first-line immunotherapy or chemo-immunotherapy
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. The Pretreatment Tumor Microenvironment Immune Status Determines Bacillus Calmette–Guerin Immunotherapy Response in Early-Stage Bladder Cancer
    Yufeng Guo, Xuezhao Ren, Ze Zhang +12
    Cancer Immunology ResearchPeer-reviewedCC BY-NC-ND 4.0Full text1 citedSurgery & anaesthesiaPMC

Cite

BibTeXRIS
BibTeX
@article{rolfo2026impact,
  title = {{458 Impact of pretreatment steroid use on neutrophiltolymphocyte ratio in patients with NSCLC receiving immunotherapy-based frontline therapy}},
  author = {Christian Rolfo and Lai Wei and Peter Shields and Jian Hu and Songzhu Zhao and Bobak Parang and Mingjia Li and Asrar Alahmadi and Carolyn Presley and Daniel Spakowicz and Jacob Kaufman and Timothy Burns and Kenneth Chian and Logan Roof and Regan Memmott and Nikhil Sekar and Jinesh S Gheeya and Dwight H Owen and Vayda Barker and Shriya Deshmukh and Jennifer Hwang and Sahana Aiyer and Sushma Jonna and David P Carbone},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0458},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0458},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 458 Impact of pretreatment steroid use on neutrophiltolymphocyte ratio in patients with NSCLC receiving immunotherapy-based frontline therapy
AU  - Christian Rolfo
AU  - Lai Wei
AU  - Peter Shields
AU  - Jian Hu
AU  - Songzhu Zhao
AU  - Bobak Parang
AU  - Mingjia Li
AU  - Asrar Alahmadi
AU  - Carolyn Presley
AU  - Daniel Spakowicz
AU  - Jacob Kaufman
AU  - Timothy Burns
AU  - Kenneth Chian
AU  - Logan Roof
AU  - Regan Memmott
AU  - Nikhil Sekar
AU  - Jinesh S Gheeya
AU  - Dwight H Owen
AU  - Vayda Barker
AU  - Shriya Deshmukh
AU  - Jennifer Hwang
AU  - Sahana Aiyer
AU  - Sushma Jonna
AU  - David P Carbone
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0458
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0458
SN  - 2051-1426
ER  -